Evidence map›Paper›PMID 33738985›Full record

ArticleAdvanced healthcare materials2021

Oxidation-Responsive, Tunable Growth Factor Delivery from Polyelectrolyte-Coated Implants.

John R Martin, MayLin T Howard, Sheryl Wang, Adam G Berger, Paula T Hammond

Open access · bronzeAbstract read
In one paragraph

Article in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Recent advances of responsive scaffolds in bone tissue engineering.Frontiers in bioengineering and biotechnology · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Encapsulated vaterite-calcite CaCOFrontiers in bioengineering and biotechnology · 2022
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

John R MartinKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.ORCID 0000-0003-1681-3818
MayLin T HowardKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Sheryl WangKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Adam G BergerKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Paula T HammondKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.ORCID 0000-0002-9835-192X
Massachusetts Institute of Technology · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Angela Nicole Koehler · 1985 to 2026
$93.9M
Tunable Nanolayer-Polymer Composite Patches for Cell-Free CMF RepairR01DE024747 · NIDCR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HAMMOND, PAULA T · 2016 to 2020
$2.1M
Environmentally-responsive, layer-by-layer coatings for the on-demand delivery of therapeutic growth factors and antibiotics to repair craniomaxillofacial bone defectsF32DE027877 · NIDCR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MARTIN, JOHN ROBERT · 2018 to 2020
$139k
NCI NIH HHS P30 CA014051NIDCR NIH HHS F32 DE027877NIDCR NIH HHS F32DE027877NIDCR NIH HHS R01 DE024747NIDCR NIH HHS R01DE024747
6 · The paper itself

Abstract

Polyelectrolyte multilayer (PEM) coatings, constructed on the surfaces of tissue engineering scaffolds using layer-by-layer assembly (LbL), promote sustained release of therapeutic molecules and have enabled regeneration of large-scale, pre-clinical bone defects. However, these systems primarily rely on non-specific hydrolysis of PEM components to foster drug release, and their pre-determined drug delivery schedules potentially limit future translation into innately heterogeneous patient populations. To trigger therapeutic delivery directly in response to local environmental stimuli, an LbL-compatible polycation solely degraded by cell-generated reactive oxygen species (ROS) was synthesized. These thioketal-based polymers were selectively cleaved by physiologic doses of ROS, stably incorporated into PEM films alongside growth factors, and facilitated tunable release of therapeutic bone morphogenetic protein-2 (BMP-2) upon oxidation. These coatings' sensitivity to oxidation was also dependent on the polyanions used in film construction, providing a simple method for enhancing ROS-mediated protein delivery in vitro. Correspondingly, when implanted in critically-sized rat calvarial defects, the most sensitive ROS-responsive coatings generated a 50% increase in bone regeneration compared with less sensitive formulations and demonstrated a nearly threefold extension in BMP-2 delivery half-life over conventional hydrolytically-sensitive coatings. These combined results highlight the potential of environmentally-responsive PEM coatings as tunable drug delivery systems for regenerative medicine.

Indexed as

Bone Morphogenetic Protein 2Bone RegenerationAnimalsDrug LiberationHumansPolyelectrolytesRatsTissue EngineeringTissue ScaffoldsBone Morphogenetic Protein 2PolyelectrolytesBMP-2boneslayer-by-layerreactive oxygen speciesresponsive drug delivery

Identifiers

PMID33738985
PMCPMC9280659
OpenAlexW3136074095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.